suziemarshall

143 POSTS 0 COMMENTS

Two companies with paclitaxel-coated devices issue corrections to published data

Medtronic
Both Medtronic and Cook Medical have issued corrections to published data regarding the safety of their paclitaxel-coated devices. While Medtronic have revised IN-PACT post-market...

Novel catheter delivering liquid paclitaxel safely and effectively prevents restenosis in...

occlusion
The efficacy and safety of a novel catheter delivering liquid paclitaxel for the prevention of restenosis in below-the-knee lesions has been confirmed by study...

Philips launches Zenition mobile C-arm platform

Zenition
Philips Zenition, a new mobile C-arm imaging platform from Philips, has launched in the USA, Germany, Austria and Switzerland. It is being introduced into...

BD receives FDA 510(k) clearance of WavelinQ 4F endoAVF system

BD has announced the 510(k) clearance from the US Food and Drug Administration (FDA) for the WavelinQ 4F endoAVF system earlier this month. The endoAVF...

Success of stereotactic radiofrequency ablation in larger tumours “challenges resection as...

SRFA
According to recent research from Reto Bale and colleagues, multi-probe stereotactic radiofrequency ablation with intraprocedural image fusion represents an efficient invasive therapy for hepatocellular...

New analysis finds “an association of survival” with drug-coated device use...

A recent US-wide, multicentre analysis has found no evidence of increased all-cause mortality associated with the use of paclitaxel-coated devices compared with non-drug-coated devices...

Promising first-time data indicate human stem cell trial is safe, prompting...

stem cell
A first-in-human, phase I clinical trial using stem cells to prevent venous stenosis formation in arteriovenous (AV) fistulas yields promising results. Sanjay Misra (Mayo...

US FDA grants premarket approval of MANTA vascular closure device

MANTA
The US Food and Drug Administration (FDA) has given premarket approval (PMA) for the MANTA vascular closure device from Teleflex. This device is the...

Biotronik introduces the first tri-axial 4F low-profile stent system

Biotronik has presented the company's Pulsar-18 T3 stent system for the first time during the Leipzig Interventional Course (LINC; 22–24 January, Leipzig, Germany).  The Pulsar-18...

Atherectomy included in pivotal study of QT Vascular’s Chocolate Touch DCB

chocolate
The FDA has granted approval to include the use of atherectomy for lesion preparation in its ongoing US pivotal study of the Chocolate Touch...

PreludeSYNC DISTAL compression device now available globally

PreludeSYNC
The PreludeSYNC DISTAL compression device (Merit Medical) is now available in US, European, Middle Eastern, African, and Asia-Pacific markets. The device is the first...

Anthony Comerota honoured with career achievement award at ISET

comerota
Anthony Comerota, of the Inova Medical Group, Alexandria, USA, received the career achievement award at the 31st International Symposium on Endovascular Therapy (ISET; 27-30...

Chelation therapy surprises experts with positive results in diabetic patients with...

chelation
A pilot study of edetate disodium-based chelation in diabetic patients with critical limb ischaemia (CLI) has positive results, leading the study investigators to “cautiously...

ISET Paclitaxel Town Hall: Vast majority of attendees will not change...

paclitaxel
The discussion around the use of paclitaxel-coated and eluting devices continues at the 31st International Symposium on Endovascular Therapy (ISET; 27-30 January 2019, Hollywood,...

Society for Cardiovascular Angiography and Interventions supports continued use of paclitaxel...

SCAI
Experts from the Society for Cardiovascular Angiography and Interventions (SCAI) have reviewed the recent meta-analysis by Katsanos and colleagues and have concluded that the...

Latest data from Philips reinforces the safety profile of Stellarex low-dose...

stellarex
A new pooled analysis of patient-level data from Philips demonstrates the “strong safety profile” of the its Stellarex drug-coated balloon (DCB) in above-the-knee studies,...

Gastric embolization unfit as standalone obesity treatment

gastric
Determining the potential role of interventional radiologists in obesity treatment is increasingly important, as the global number of obese patients has long since swollen...

BIBLIOS trial has obtained ethics approval and initiated patient enrolment

BIBLIOS
The BIBLIOS trial has received Ethics Committee (EC) approval, and enrolled its first patient. This announcement comes from Wouter Lansink, who will be treating this...

Smoking cigarettes associated with increased risk of peripheral arterial disease in...

cigarette
African Americans who smoke cigarettes are more likely than those who do not smoke to develop peripheral arterial disease (PAD), according to new research...

Nellix system CE Mark suspended

CE
The CE Mark for the Nellix endovascular aneurysm sealing system (Endologix) has been suspended by its Notified Body, GMED, following a voluntary recall and...

Patient-level survival analysis demonstrates no link between paclitaxel dose and mortality...

Medtronic
New data on the IN.PACT Admiral drug-coated balloon (DCB; Medtronic) in patients with peripheral arterial disease (PAD) in the superficial femoral (SFA) and popliteal...

Data presented at LINC confirm the safety and effectiveness of Zilver...

Findings presented at the Leipzig Interventional Course (LINC; 22–25 January 2019, Leipzig, Germany) contradict the results of a meta-analysis published in the Journal of...

Number of studies authored by female IRs on the rise

female
Women are equally as productive as men in terms of number of publications, citations, and grants, a recent study investigating the impact of women...

Preliminary in vitro data is promising for Anaconda Biomed’s advanced thrombectomy...

Preliminary in vitro data on Anaconda Biomed’s advanced thrombectomy system showed that the reperfusion rates with this novel system outperformed competing mechanical thrombectomy devices...

US government shutdown disrupting FDA work

shutdown
The US government shutdown means the country’s Food and Drug Administration (FDA) cannot accept new user fees, which means the agency cannot accept new...

Philips launches Azurion with FlexArm to aid image-guided procedures

Azurion
Philips launches its Azurion with FlexArm platform to aid patient imaging and positioning during image-guided procedures. Azurion with FlexArm allows clinicians to intraoperatively visualise patient...

Weighing up the radiation risks in CT-guided vs. fluoroscopy-guided spinal injections

spinal
New research published in Radiology reports that CT-guidance is just as effective a tool for allowing interventional radiologists (IRs) to perform lumbar spinal injections...

Paediatric IR is coming of age

paediatric
Honoured as the Royal College of Radiologists (RCR)/ British Society of Interventional Radiology (BSIR) travelling professor for 2017–2018, Alex Barnacle delivered the Graham Plant...

New DVT device completes first-in-human trial

vetex
The first-in-human case using the new deep vein thrombosis (DVT) device Vetex thrombectomy catheter (Vetex Medical) has recently been completed in a multicentre study....

Medtronic and Boston Scientific stand by paclitaxel devices despite Katsanos’ critical...

medtronic
Speaking to investors at the JP Morgan healthcare conference in San Francisco, executives from Medtronic and Boston Scientific said their data do not show...

Stereotactic radiofrequency ablation is effective even in tumours over 3cm, study...

stereotactic
Multi-probe stereotactic radiofrequency ablation (SRFA) with intraprocedural image fusion represents an efficient minimally invasive therapy for hepatocellular carcinoma (HCC), even with tumour sizes larger...

Rural communities have limited access to IR services in the USA

rural
  The results of an American College of Radiology (ACR) survey find that small hospitals and rural communities experience greater difficulty recruiting and retaining interventional...

Establishing an interventional radiology unit in Uganda

Uganda
It is time to change patient care for an entire country, writes Gregory Makris. After travelling to Uganda and learning that the country’s 40...

IZI Medical acquires Quick-Core biopsy and breast localisation needle assets from Cook...

IZI
IZI Medical Products (IZI) has acquired select soft tissue biopsy and breast localisation needle assets from Cook Medical.  The acquired portfolio of products is...

Cryoablation shows promise in treating low-risk breast cancers

cryoablation
Cryoablation shows early indications of effectiveness in treating women with low-risk breast cancers, according to research presented at the annual meeting of the Radiological...

Tack Endovascular System launches in the EU with first commercial use...

The first commercial use of the Tack Endovascular System (Intact Vascular) has taken place in multiple hospitals within Germany. A novel therapy for dissection...

QuiremScout, the first and only product indicated for SIRT work-up, receives...

SIRT
QuiremScout (Quirem Medical) has received CE mark, making it available for clinical centres throughout Europe. QuiremScout is designed to advance the SIRT (selective internal...

Unrestricted sales of the Nellix System to cease as use is...

CE
Unrestricted sales and use of the Nellix System (Endologix) will cease immediately, in order to ensure optimal outcomes for patients, according to Endologix. The...

Unique therapeutic approach to treating uncontrolled hypertension receives US$77 million financing

Ablative Solutions has announced the first close of its US$77 million Series D funding round. The round was led by new investor Glide Healthcare,...

TOBA II BTK clinical trial completes enrolment

enrolment
The Tack Optimised Balloon Angioplasty II below-the-knee (TOBA II BTK) clinical trial has successfully completed enrolment, ahead of schedule. This study, sponsored by Intact...

BD’s Lutonix 018 DCB approved by FDA to treat SFA disease

Lutonix
The FDA has granted approval for BD’s 0.018-inch guidewire-compatible Lutonix 018 drug-coated balloon (DCB) for the treatment of long superficial femoral artery lesions in...

Pooled analysis of four RCTs finds drug-coated balloons superior to plain...

pooled
A pooled analysis of four randomised controlled trials finds drug-coated balloon (DCB) angioplasty superior to plain angioplasty in patients with femoropopliteal artery disease, irrespective...

Otsuka Medical Devices completes aquisition of Veryan Medical

Otsuka Medical Devices, a 100% subsidiary of Otsuka Holdings Co., Ltd., and Veryan Medical have announced the completion of the acquisition of Veryan by...

Using TEVAR to treat aortic dissection improves survival over open repair

TEVAR
Thoracic endovascular aortic repair (TEVAR) demonstrates a one- and five-year survival advantage over the current “gold standard” practice of medical therapy in the treatment...

Merit Medical acquires Vascular Insights

Merit
Merit Medical has acquired substantially all of the assets of Vascular Insights, based in Quincy, USA. Vascular Insights’ primary assets are the ClariVein IC...

European Society of Radiology and GE Healthcare announce exclusive artificial intelligence...

The European Society of Radiology (ESR) and GE Healthcare are partnering on artificial intelligence for the upcoming European Congress of Radiology (ECR; 27 February–3...

12-month data show UroLift system a good treatment option for men...

UroLift
Twelve-month data from the multicentre prospective MedLift study of the Urolift system (NeoTract, a Teleflex subsidiary) for benign prostatic hyperplasia (BPH) involving a median...

Prelude IDeal hydrophilic sheath launches

IDeal
The Prelude Ideal hydrophilic sheath introducer (Merit Medical) has launched in European, Middle Eastern and African markets. The Prelude Ideal is designed primarily for use...

New ATTRACT data show catheter-based therapy significantly reduces leg symptoms and...

PTS
A new study, recently published online in the journal Circulation, reports on outcomes from a subgroup of 391 patients with acute iliofemoral deep venous...

Retrospective review suggests microwave ablation of HCC in the elderly is...

microwave
Treating hepatocellular carcinoma (HCC) with microwave ablation is safe in the elderly population, the first study investigating the efficacy and safety profile of this...

Without additional long-term and patient-level data, Katsanos et al’s conclusion is...

paclitaxel
By Thomas Zeller The Katsanos et al meta-analysis reports an increased risk of mortality beyond one year across randomised studies of paclitaxel-coated balloons (DCB) and...

First successful implantation of the bioconvertible Sentry IVC filter

The world’s first bioconvertible IVC filter commercially offered in the USA (Sentry; from BTG) has been successfully implanted into the first patients outside of...

EmboCube embolization gelatin granted FDA approval for embolization of hypervascular tumours

embolization
EmboCube Embolization Gelatin (Merit Medical) has been granted 510(k) approval for use in embolization of hypervascular tumours. The uniformly cut cubes of gelatin foam have...

Pulsed radiofrequency relieves acute back pain and sciatica

pulsed radiofrequency
CT-guided pulsed radiofrequency is safe and effective in people with acute lower back pain that have not responded to conservative treatment, according to a...

Interventional radiology among the most competitive medical specialties of 2018 in...

competitive
Integrated interventional radiology has been listed among the American Medical Association’s (AMA) seven most competitive medical specialties in 2018. “The National Resident Matching Program considers...

Gastric embolization leads to loss of muscle as well as fat

Left gastric artery embolization leads to the loss of both fat and muscle, according to a new study presented at the annual meeting of...

Sentry Bioconvertible IVC filter two-year results show zero tilt or migration

Two-year results for the SENTRY trial were presented at the Vascular Interventional Advances conference (VIVA; 5–8 November, Las Vegas, USA). The prospective, multicentre trial...

Why ISET 2019 is a must-attend meeting: Insight from a multidisciplinary...

ISET
For three decades, the International Symposium on Endovascular Therapy (ISET) has been providing clinicians with premier endovascular education. In 2019, ISET is investing in...

COVERA Vascular Covered Stent for the treatment of venous anastomotic stenosis...

This case report has been sponsored by BD. Panagiotis M Kitrou, consultant interventional radiologist, and Dimitrios Karnabatidis, professor of Interventional Radiology, both at Patras University...

Essential radiation protection for the modern interventionalist

protection
Addressing the importance of radiation protection for the modern interventionist, Kevin Mani writes about the need for knowledge and training in radiation protection for...

Gerard Goh

President of the Interventional Radiology Society of Australasia (IRSA) and European Board of Interventional Radiology (EBIR) examiner for Australia and New Zealand, Gerard Goh...

Mapping the future of interventional oncology: “The time to study augmented...

augmented reality
“I used to sneak away to the arcade at seven years old to play pacman and asteroids; our goal with augmented reality really is...

Interventional oncology established in “mainstream” cancer care with world-first clinical symposium

Oncology
The world-first collaboration between interventional oncology (IO) and radiation oncology, embraced by the Trans-Tasman Radiation Oncology Group (TROG), continues to bear fruit, with the...

CASE REPORT: SFA-CTO Recanalization by using the novel 0.035″ ULTRASCORE Focused...

Ultrascore
This case report is sponsored by BD. Ralf Langhoff, chief, Angiology/Vascular Medicine, Sankt Gertrauden-Krankenhaus, Berlin, Germany, reports on a case in which his team used...

The future of interventional radiology rests on the creativity and innovation...

Described by her supervisor Glen Schlaphoff (Sydney, Australia) as "a perfect example of a young up and coming interventional radiologist", Sindhura Nirmalarajan is a...

Interventional radiologists’ expertise essential in trauma embolization

Trauma
With traumatic injuries caused by traffic accidents on the rise, Miguel Angel de Gregorio provides an overview of interventional radiologists' role in performing embolization...

Stem cell therapy is the future of critical limb ischaemia management

Stem cell
Addressing the audience at the 33rd annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 22–25 September, Lisbon, Portugal), Sanjiv Sharma...

SIR advocates for a reallocation of Capitol funding to increase interventional...

SIR
At the third Capitol briefing from the Society of Interventional Radiology (SIR), Susan Sedory, executive director for SIR, along with a panel of experienced...

Boston Scientific announces recommended offer to acquire BTG

Boston
Boston Scientific has announced it has reached an agreement on the terms of a recommended offer to acquire BTG, a company headquartered in the...

Interventional News Issue 72—November 2018 US Edition

issue
Issue highlights: Expanding horizons in critical limb ischaemia treatment may benefit "no option" patients Interventional radiology societies call for expanded stroke training Comment: Stem...

Interventional News Issue 72—November 2018

Issue highlights: Expanding horizons in critical limb ischaemia treatment may benefit "no option" patients Interventional radiology societies call for expanded stroke training Comment: Stem...

Lutonix BTK randomised trial meets safety and efficacy endpoints at six...

Six-month outcomes of a multicentre randomised controlled trial using the Lutonix 014 drug-coated balloon (BD; DCB) has demonstrated the DCB is safe to use...

IN.PACT SFA five-year outcomes show sustained benefits of drug-coated balloon in...

The IN.PACT SFA trial’s co-principal investigator John Laird, from the Adventist Heart and Vascular Institute in St. Helena, USA, has presented the five-year outcomes...

Same day release for uterine fibroid embolization patients at Royal Stoke...

uterine
Clinicians based at the Royal Stoke University Hospital (Stoke-on-Trent, UK) have developed a new protocol for uterine fibroid embolization (UFE), introducing a day case...

Transradial Embolotherapy

transradial
This educational supplement, sponsored by Merit Medical, focuses on using transradial access in a range of contexts. Contents Microcatheters for prostatic artery embolization: Attila Kovács...

Interventional Radiology profile rises in medicine and at RSNA meeting

RSNA
For the first time at an annual meeting of the Radiological Society of North America (RSNA; 25–30 November, Chicago, USA), interventional radiology (IR) companies...

Enrolment begins in new atherosclerotic lesions study in the superficial femoral...

The first peripheral arterial disease (PAD) patient with disease in the superficial femoral and popliteal arteries has been successfully enrolled in the FORTEZ study....

Rivaroxaban receives peripheral arterial disease indication in Europe and USA

Rivaroxaban
Rivaroxaban (brand name Xarelto, Bayer) has received approval from the US Food and Drug Administration (FDA) and the European Commission to reduce risks in...

Eximo Medical receives FDA clearance for B-Laser atherectomy system to treat...

Eximo Medical has announced it has received 510(k) clearance from the US Food & Drug Administration (FDA) for its B-Laser atherectomy system for peripheral...

Avinger receives CE marking approval for Pantheris SV

Avinger, a developer of treatments for peripheral arterial disease (PAD), has announced Conformité Européenne (CE) Marking approval of Pantheris SV (Small Vessel), a product...

Valiant Navion thoracic stent graft receives FDA approval

The US Food and Drug Administration (FDA) has approved Valiant Navion thoracic stent graft system (Medtronic) for the minimally invasive repair of all lesions...

Strategies needed to address radiation exposure risks during venous procedures

Research presented at the European Society for Vascular Surgery’s annual meeting (ESVS; 25–28 September, Valencia, Spain) has shone a light on the potentially high...

Leap: The tiny camera that will disrupt intravascular imaging

Leap
A single-use, high-definition miniature camera has been hailed as a "breakthrough innovation" in intravascular surgery, as Cambridge Consultants announced the device's launch. Called Leap,...

The merits of a 100-year business plan

Business
Fred Lampropoulos, chairman and chief executive officer of Merit Medical, spoke to Interventional News about building a business with lasting value in mind. He...

Interventional News Issue 71—September 2018 US Edition

Issue highlights: Embolization improves benign prostatic hyperplasia symptoms nearly as much as transurethral resection of the prostate (TURP) does A recent study reports that...

Interventional News Issue 71—September 2018

Issue highlights: Embolization improves benign prostatic hyperplasia symptoms nearly as much as transurethral resection of the prostate (TURP) does A recent study reports that...

A “mediocre success rate” found for coil embolization to obtain intrahepatic...

coil
Coil embolization of hepatic arteries to induce redistribution of blood flow and microspheres has a mediocre success rate, concluded a recent study presented by...

Lessons from randomised controlled trials utilising SIRT in liver cancer

A recent session at CIRSE 2018 sought to go beyond the headline findings from a number of recent randomised controlled trials (RCTs) in interventional...

Phase III RCTs needed to prove radiofrequency ablation is effective against...

RCTs
Interventional radiologists must become involved in the multidisciplinary development of phase III randomised controlled trials (RCTs) to further assess the role of radiofrequency ablation...

Acessa Health wins FDA nod for 3rd generation ProVu

ProVu
Acessa Health has announced that the company has received US Food and Drug Administration (FDA) 510(k) clearance for its third generation Acessa ProVu radiofrequency ablation...

Guerbet announces appointment of Leeann Essai as North American head of...

Essai
Leeann Essai has joined Guerbet’s executive team as North American head of marketing. In this role, Essai will report to Massimo Carrara, Guerbet vice president...

Interim results of the Lutonix drug-coated balloon in a complex patient...

Lutonix
This article is sponsored by BD. In a complex patient population with advanced, symptomatic below-the-knee peripheral artery disease, treatment with the Lutonix drug-coated balloon (BD)...

Paclitaxel DCB no better than placebo to treat stenosis in patients...

paclitaxel
In a study evaluating the efficacy of a drug-coated balloon (DCB) in inhibiting restenosis and ensuring long-term patency in patients with arteriovenous fistulae (AVF),...

Covered stent provides greater patency than angioplasty alone in AV fistulae

covered
The Covera vascular covered stent (BD) has a superior six-month primary patency rate than standard balloon angioplasty, with an equivalent safety at 30 days,...

New resorbable embolic agent for uterine fibroid embolization is effective

A new, spherical resorbable gelatine embolic agent, GelBead, has been shown to be “very effective” for uterine fibroid embolization (UFE). Nigel Hacking (Department of...

Real-time imaging: Ultrasound detects a biodegradable embolic microsphere after prostatic artery...

Researchers report the use of ultrasound to detect embolization in real time for patients undergoing treatment for benign prostatic hyperplasia (BPH). Richard Owen (University...

Live from CIRSE 2018: Three-year results from global study confirm the...

The largest prospective, independently-adjudicated study of drug coated balloons (DCBs) in a broad range of lesions in real-world patients confirms the safety and performance...

Eluvia outperforms Zilver PTX in IMPERIAL 12-month results

The Eluvia drug-eluting vascular stent system (Boston Scientific) shows superior primary patency compared to the Zilver PTX drug-eluting stent (Cook Medical), concludes the 12-month...

ICEfx cryoablation system launches globally at CIRSE 2018

ICEfx
BTG has announced the global launch of its ICEfx cryoablation system. This is an evolution of the existing Visual ICE system, and according to...

Merit significantly expands biopsy portfolio with release of new bone biopsy...

Merit
  Merit Medical Systems has announced the expansion of its biopsy portfolio, with the release of five new manual bone biopsy systems. According to a...

Cook Medical announces successful resolution of 2014 FDA warning letter

warning
Cook Medical has announced that it received a close-out letter from the US Food and Drug Administration (FDA) resolving a 2014 warning letter for...

International neurointerventional societies outline new criteria for facilities that treat stroke

competitive
  Thirteen neurointerventional societies have released new guidelines outlining the criteria for Level 1, 2 and 3 stroke centres that provide acute ischemic stroke interventions...

New Sniper balloon occlusion microcatheters cleared in Europe

Sniper
Embolx, a new medical device company out of Silicon Valley, has been given the European CE mark for its latest Sniper balloon occlusion microcatheters....

Boston Scientific announces agreement to acquire Augmenix

SpaceOAR
  Boston Scientific has announced that it has entered into a definitive agreement to acquire Augmenix, a privately-held company which has developed and commercialised the...

The IR residency necessity

Residency
With the graduation of the first ever interventional radiology residents from a US university, Wael Saad and Minhaj Khaja discuss the importance of having a...

Involving interventional oncologists in gene therapies could cut the prohibitive costs

gene
Daniel Sze (Stanford University, Stanford, USA), presenting at the European Conference on Interventional Oncology Annual Meeting (ECIO; 22–25 April, Vienna, Austria), calls for a...

AngioDynamics provides update on vascular access business

AngioDynamics has provided a corporate update and acknowledged a recent, favourable US District Court ruling that impacts its vascular access business. A press release states...

Bayer announces new licensed indication for use of Xarelto in patients...

Xarelto, co-administered with aspirin, is indicated in the EU for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or...

Gynesonics receives US FDA clearance to market Sonata system for ablation...

Sonata
Gynesonics announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Sonata sonography-guided transcervical fibroid ablation...

Novel technique to treat endometrial cysts is safe and effective

Endometriosis
Catheter-based sclerotherapy is a safe and effective treatment for endometrial cysts and could help preserve fertility in patients, according to a study published in...

Top trends in ablation in 2018

ablation
Roberto Iezzi provides an overview of ablative therapies, and what interventional radiologists can expect from ablation procedures in the near future. Amongst the emerging...

CT-guided radiofrequency thermal ablation a safe alternative to surgery for HCC...

radiofrequency
Percutaneous CT-guided radiofrequency thermal ablation is a safe and effective alternative treatment option in patients with pulmonary metastases from hepatocellular carcinoma (HCC) that cannot...

Scotland on red alert over shortage of interventional radiologists

Scotland
Interventional radiologists issued a red alert warning over staff shortages in Scotland as the only full-time specialists based in the Scottish Highlands step down....

Guerbet announces commercial partnership with Imalogix

Guerbet has announced a commercial partnership with Imalogix, a company focusing on artificial intelligence process and workflow solutions. The commercial partnership combines Guerbet's diagnostic...

Move to less invasive medicine is “one of the greatest shifts...

Barry Katzen
“Innovation has driven my life in interventional radiology—and what a ride it has been,” said Barry Katzen, founder and chief medical executive of Miami...

Percutaneous ablation outperforms surgery in the treatment of renal cell carcinoma

renal carcinoma
Percutaneous ablation can be successfully used to treat many cases of early-stage renal cell carcinoma, a new study published in the Annals of Internal...

Researchers find major inequalities in acute stroke treatment across Europe

Every year, up to 1.3 million people in Europe suffer a first stroke. Acute stroke treatment strategies such as acute treatment of patients in...

Preconceived notions, alternative facts and fake news: How we decide what...

facts
“In this era, it is common for people not to accept basic scientific data. This has now permeated society so much that people feel empowered...

Imaging-guided sister disciplines radiation oncology and interventional oncology “should build on...

oncology
Collaboration in matters of training, research and clinical practice between radiation oncology (RO) and interventional oncology (IO) could significantly advance research into local therapies, benefit patients...

CIO to separate from ISET in 2019

The Symposium on Clinical Interventional Oncology (CIO) will separate from the International Symposium on Endovascular Therapy (ISET) starting from next year. Beginning in 2019,...

HIFU shows outcomes in line with surgery for significant nonmetastatic prostate...

SonaCare Medical has reported five-year outcomes from a multicentre study of 625 medium to high-risk clinically significant nonmetastatic prostate cancer patients following focal therapy...

Deficiencies in operator behaviour: Premature atypical malignancies in high-volume operators

Radiation
In this article, Bijan Modarai outlines recent research on the effects on radiation exposure in high-volume interventionists, why a future with alternative modalities to X-ray guided...

Augmented reality can lend you the “eyes of the first operator”

Augmented reality
In February 2018, the first European case of endovascular aneurysm repair (EVAR) for the treatment of an abdominal aortic aneurysm was performed using a prototype device...

Reviewing five years of deep venous stenting: What comes next?

Stenting
For many venous specialists, dedicated venous stents represent the future—and the promise of an ideal venous stent on the horizon is a central topic...

Flowing on the horizon: Liquid embolics in development

Embolics
To become a mainstay liquid embolic for peripheral use, an optimal product should be easy to use, have reproducible and controllable deep penetration for...

Evidence propels prostate artery embolization into becoming a “standard of care”...

embolization
The support of the UK’s National Institute for Health and Care Excellence (NICE) signals that embolization has a unique role in the treatment of benign prostatic...

Interventional News Issue 70 – June 2018 US Edition

Issue highlights: Imaging-guided sister disciplines radiation oncology and interventional oncology “should build on common ground” UK’s NICE recommends prostate artery embolization for selected men...

Interventional News Issue 70 – June 2018

Issue highlights: Imaging-guided sister disciplines radiation oncology and interventional oncology “should build on common ground” UK’s NICE recommends prostate artery embolization for selected men...

Interventional News Issue 69 – April 2018 US Edition

Highlights: 69 Strike now to perform stroke thrombectomy Head-to-head comparison of Ranger and IN.PACT drug-coated balloons Brave Dreams trial finds venoplasty “safe, but largely ineffective”...

Vectorio®: Efficacy and safety for improved cTACE mixing and delivery

This educational supplement, sponsored by Guerbet, is intended for readers in the EU only. Guerbet obtained the CE mark for its conventional transarterial chemoembolization...

Establishing the evidence base for SIRT in Interventional Oncology

Multidisciplinary oncology thought leaders discuss the personalisation of SIRT, new and recent evidence for the minimally invasive procedure over sorafenib in advanced HCC, the...

WCIO 2018 puts biopsy front and centre of the interventional oncology...

The opening plenary at the World Conference on Interventional Oncology (WCIO; 7–10 June, Boston, USA) put biopsy, which is considered a mundane procedure by...

Ally Bridge Group expands early-stage cancer solution portfolio with investment in...

Ally Bridge Group (ABG), a cross-border life science investment group, has completed a Series A investment, as the first part of a total of...

Stephen B Solomon

Stephen B Solomon, chief, Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, New York, USA and president of the Society for Interventional Oncology (SIO)...

IR: An entirely suitable job for a woman

There is no “stereotypical” female interventional radiologist. We are simply as skilled, motivated, committed, and diverse in our interests as our male colleagues. Yet,...

Guerbet launches two new microcatheters for use in embolization procedures

Guerbet has announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumour and vascular aneurysm embolization procedures. The company introduced the...

Med Alliance raises US$37 million to launch sirolimus drug-coated balloon

Med Alliance SA, a company developing and commercialising the first sirolimus micro-reservoir drug-coated balloon (SELUTION DCB) to treat patients suffering from peripheral artery disease...

Interventional News Issue 69 – April 2018

Highlights: Strike now to perform stroke thrombectomy Head-to-head comparison of Ranger and IN.PACT drug-coated balloons Brave Dreams trial finds venoplasty “safe, but largely ineffective”...

Potential synergies of immuno-oncology with interventional oncology

The questions of if, how and when to combine interventional oncological procedures with systemic immunotherapy are on the tip of everyone’s tongue, from multidisciplinary tumour boards...

Strike now to perform stroke thrombectomy

Should interventional radiologists up-skill to perform emergency stroke thrombectomy and help deliver stroke services? And if they did, would the increase in the number...

FDA releases final rule on acceptance of data from clinical investigations...

The Food and Drug Administration (FDA) has today issued the final rule on “human subject protection; acceptance of data from clinical investigations for medical...

Robert Morgan

Robert Morgan, consultant vascular and interventional radiologist, St George’s Hospital, London, chairman of the CIRSE EBIR committee and a deputy editor on CVIR, told Interventional News...

Bob Abraham

Canada’s recent recognition as a subspecialty at the national level has helped to raise awareness amongst other disciplines, healthcare policymakers and hospital administrators. “We...